|
Novatek's 9M07 IAS financials improved on the same period last year. The company managed to boost earnings growth compared to costs. Meanwhile, an upsurge in capex could take a toll on the gas producer's financial indicators further down the road.
Novatek (RTS: NVTK) released consolidated interim abridged IAS financials for Q307 and 9M07. The company posted significant revenue growth in the reporting period due to higher hydrocarbon sales and higher average selling price. In Q307 natural gas sales dropped y-o-y due to lower sales to traders. In H107 opex grew stronger than revenue, while the company managed to reverse the situation in Q307. At present earnings growth outpaces costs.
Novatek's IAS financials, $ mln
| | 9M07 | 9M06 | 9M07/9M06 |
| Revenue |
1,759 |
1,363 |
+29.0% |
| Opex |
1,047 |
817 |
+28.1% |
| Operating profit margin |
40% |
40% |
+0.4% |
| Profit before income tax |
454 |
346 |
+31.5% |
| Net profit |
529 |
414 |
+27.9% |
| Net profit margin |
30% |
30% |
-0.3% |
Source: Company data, Finam estimates
However, a rise in non-operating expenses due to higher expenses on losses for exchange rate differences impacted net profit margin, which softened 0.3%. In H107, net profit margin dipped 1.1%. We believe that in FY07 the company will strengthen net margin. Novatek's capex climbed more than 4-fold, which could impact the company's financials longer term.
Hydrocarbon sales
| | 9M07 | 9M06 | 9M07/9M06 |
| Natural gas (mln cu m) |
23,480 |
22,614 |
+3.8% |
| Stable gas condensate (th tons) |
1,210 |
1,026 |
+17.9% |
Source: Company data, Finam estimates
We view 9M07 financials as positive, since they showed a turnaround in a trend of robust cost growth compared to revenues. That said, an upsurge in capex could take a toll on the company's financials.
At present we have no recommendation on Novatek shares.
Konstantin Reily
Other comments of the day
|
Novatek
Capitalization: $6 831 688 500,00
Common shares:
Price: $2,25
Delta week: -11,8%
Delta month: -37,5%
Delta year: -67,2%
|